The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial(†)

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) seems to be induced by the ovarian release of vascular endothelial growth factor (VEGF), which increases vascular permeability. Dopamine agonists inhibit VEGF receptor phosphorylation and thereby decrease vascular permeability. METHODS: A randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Busso, Cristiano, Fernández-Sánchez, Manuel, García-Velasco, Juan Antonio, Landeras, José, Ballesteros, Augustín, Muñoz, Elkin, González, Sandra, Simón, Carlos, Arce, Joan-Carles, Pellicer, Antonio
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839910/
https://www.ncbi.nlm.nih.gov/pubmed/20139430
http://dx.doi.org/10.1093/humrep/deq005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839910/
https://www.ncbi.nlm.nih.gov/pubmed/20139430
http://dx.doi.org/10.1093/humrep/deq005

Ejemplares similares